JP2004510772A5 - - Google Patents

Download PDF

Info

Publication number
JP2004510772A5
JP2004510772A5 JP2002532439A JP2002532439A JP2004510772A5 JP 2004510772 A5 JP2004510772 A5 JP 2004510772A5 JP 2002532439 A JP2002532439 A JP 2002532439A JP 2002532439 A JP2002532439 A JP 2002532439A JP 2004510772 A5 JP2004510772 A5 JP 2004510772A5
Authority
JP
Japan
Prior art keywords
groups
pyrrolo
thienyl
formula
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002532439A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004510772A (ja
JP4927306B2 (ja
Filing date
Publication date
Priority claimed from EP00810886A external-priority patent/EP1193267A1/en
Application filed filed Critical
Publication of JP2004510772A publication Critical patent/JP2004510772A/ja
Publication of JP2004510772A5 publication Critical patent/JP2004510772A5/ja
Application granted granted Critical
Publication of JP4927306B2 publication Critical patent/JP4927306B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002532439A 2000-09-27 2001-09-27 タンパク質Jun−キナーゼのインヒビターとしての医薬的活性親水性スルホンアミド誘導体 Expired - Fee Related JP4927306B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00810886A EP1193267A1 (en) 2000-09-27 2000-09-27 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases
EP00810886.2 2000-09-27
PCT/IB2001/001771 WO2002028856A1 (en) 2000-09-27 2001-09-27 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases

Publications (3)

Publication Number Publication Date
JP2004510772A JP2004510772A (ja) 2004-04-08
JP2004510772A5 true JP2004510772A5 (https=) 2012-01-19
JP4927306B2 JP4927306B2 (ja) 2012-05-09

Family

ID=8174936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002532439A Expired - Fee Related JP4927306B2 (ja) 2000-09-27 2001-09-27 タンパク質Jun−キナーゼのインヒビターとしての医薬的活性親水性スルホンアミド誘導体

Country Status (8)

Country Link
US (1) US20040077632A1 (https=)
EP (2) EP1193267A1 (https=)
JP (1) JP4927306B2 (https=)
AU (2) AU8799001A (https=)
CA (1) CA2421417A1 (https=)
ES (1) ES2392039T3 (https=)
IL (1) IL154966A0 (https=)
WO (1) WO2002028856A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1193268A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
EP1193256A1 (en) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
ES2318041T3 (es) * 2001-07-23 2009-05-01 Laboratoires Serono Sa Derivados de arilsulfonamida como inhibidores de c-jun quinasas (jnk) n-terminales.
AU2004271741A1 (en) * 2003-09-12 2005-03-24 Laboratoires Serono Sa Sulfonamide derivatives for the treatment of diabetes
JP5080241B2 (ja) * 2004-04-08 2012-11-21 メルク セローノ ソシエテ アノニム Jnk阻害剤およびスクロスポリンを含んでなる組成物
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
WO2007141224A2 (en) * 2006-06-02 2007-12-13 Laboratoires Serono Sa Jnk inhibitors for treatment of skin diseases
US20100240720A1 (en) * 2009-03-20 2010-09-23 Burnham Institute For Medical Research Allosteric jnk inhibitors
WO2011060321A1 (en) 2009-11-16 2011-05-19 Chdi, Inc. Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
US8889716B2 (en) 2011-05-10 2014-11-18 Chdi Foundation, Inc. Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
CN112663077B (zh) * 2021-01-11 2022-07-01 陕西师范大学 一种苯并磺内酰胺类化合物的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553414B1 (fr) * 1983-10-18 1986-08-14 Choay Sa Nouveaux benzenesulfonamides n-cyclises, leur procede de preparation et leur utilisation comme substance active de compositions pharmaceutiques
WO1991013872A1 (en) 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
US5106983A (en) 1990-04-30 1992-04-21 The United States Of America As Represented By The Secretary Of The Army Process of making carfentanil and related analgesics
US5238950A (en) * 1991-12-17 1993-08-24 Schering Corporation Inhibitors of platelet-derived growth factor
US5576313A (en) 1994-08-29 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5744320A (en) * 1995-06-07 1998-04-28 Promega Corporation Quenching reagents and assays for enzyme-mediated luminescence
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
AR019322A1 (es) * 1998-06-18 2002-02-13 Smithkline Beecham Corp Derivados de sulfonilo sustituido por heterociclo-etanodionanilina sustituida por heterociclo, composicion farmaceutica que los contiene y su uso para lamanufactura de un medicamento
CN1332943C (zh) * 1998-07-08 2007-08-22 萨诺费-阿文蒂斯德国有限公司 硫取代的磺酰基氨基羧酸n-芳基酰胺,其制备方法、用途以及含有该化合物的药物制剂
EP1088821A1 (en) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives
EP1193256A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
EP1193268A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases

Similar Documents

Publication Publication Date Title
JP2004510772A5 (https=)
CA2359948A1 (en) Triazole compounds with dopamine-d3-receptor affinity
WO2003004472A8 (en) Arylamines for the treatment of conditions associated with gsk-3
WO2000046198A8 (en) Anti-inflammatory indole derivatives
JP2002540253A5 (https=)
Caton et al. Etiology of periodontal diseases
CA2200707A1 (en) Novel prostaglandin synthase inhibitors
CA2206532A1 (en) Novel amidinonaphthyl derivative or salt thereof
JP2005538124A5 (https=)
WO2004087699A3 (en) Thiazoles useful as inhibitors of protein kinases
WO2004096134A3 (en) Substituted 1,4-diazepines and uses thereof
CA2408602A1 (en) Phenylglycine derivatives
MX2007012090A (es) Derivados sustituidos de pirazoliloxifenilo como herbicidas.
SI2228064T1 (sl) Farmacevtski sestavek, ki vsebuje glikopirolat in agonist adrenoceptorja beta2
HRP20110295T1 (hr) Agonisti receptora niacina, smjese koje sadržavaju takve spojeve i postupci liječenja
JP2007505105A5 (https=)
JP2004315386A5 (https=)
JP2002521447A5 (https=)
JPH09235233A5 (https=)
ATE343384T1 (de) Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
WO2003080617A8 (en) Pyrazolopyrimidine derivatives
RU2003138078A (ru) Имидазотриазиноновые производные и их применение против воспалительных процессов и/или иммунных заболеваний
FR2793246B1 (fr) Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2528493A1 (en) Medicinal composition containing triazole compound
Shelke et al. ULTRASOUND MEDIATED SYNTHESIS AND BIOLOGICAL ACTIVITY OF NEW THIAZOLES DERIVATIVE